The world is now facing a new crisis

The cause of this crisis is the invisible enemy, no one is free from its clutches now. But our preparation for dealing with it was said to be in the void.
In the face of the outbreak of war in China, some far-flung countries have shunned “your problem is not mine”, or in some cases have blamed China for creating the crisis. They too soon realized that this invasion of the invisible enemy was not aimed at a single country, but at mankind. The world is Now facing invisible enemies.

We now understand this better as coronavirus infections have spread around. As a result, we have no choice but to resist the enemy unitedly around the world in order to continue our progress by ensuring victory in this war.

The coronavirus, on the other hand, has brought a new message to this conflicting world: No one can be out of danger unless he fights the invisible enemy hand in hand without wasting his energy in a shadowy war against each other to establish dominance. We have already begun to notice some examples of such unprecedented alliances in times of extreme crisis.
As a result, the whole world is united in the fight against this invisible enemy.

The medical community around the world is at the forefront of the fight to defeat the enemy that is simultaneously advancing on several fronts. It is now clear to them that they have chosen this profession not only to earn money, but also to serve humanity first and foremost. And we are also noticing that their own lives are being jeopardized in the service of humanity. But despite the risks, they deserve praise for the professional responsibilities they and health workers around the world continue to perform.

Along with doctors, another group of fighters who are relentlessly trying to free mankind from this crisis is the medical researchers. They are engaged in the struggle to defeat the enemy by inventing new drugs. This team includes researchers from both the public and private sectors. At this time they are running at a lot of rocket speed to achieve the goal. Their contribution and sacrifice remained hidden from the public eye. However, their success in dealing with the coronavirus is not small.

Viruses or invisible germs have been around us since the beginning of time. However, when these germs become insane for some special reason and transform themselves and enter the human body, then the danger occurs. What causes germs to go insane is, of course, a different matter. However, the beginning of this trend seems to be from the time when people started engaging in horrible activities like using germs as a weapon out of the desire to kill their own enemy.

The greatest use of germ weapons was seen in the First World War, and soon after that the insane germs spread around and began to kill people. At that time, 50 million people died in the epidemic known as the Spanish flu. Of course, there is no such thing as a crazy corona flu outbreak this time around. Because in spite of various international sanctions and laws, the powerful countries of the world are not lagging behind in testing nuclear weapons in secret.
On the contrary, the hopeful aspect is that the study of germ control is also advancing rapidly around the world.

Researchers working on that task are now working silently in an attempt to find a way to kill the coronavirus. They sound like they’re running out of time, but they’re not far from success. Some recent discoveries and inventions in Japan are giving us that message.

The first news of the practical success of the drug in the treatment of coronavirus came from China. The discovery by a company of Fuji Film Holding Group of Japan in the treatment of patients infected with the virus in China The use of Avigan helps many patients to recover from the disease. As a result, Avigan continues to be used in the treatment of coronavirus in China. Avigan was created to treat common influenza. Its practical success against coronavirus seems to be a coincidence.

However, the company’s researchers are trying to make it suitable for coronavirus treatment by modifying its chemical composition. Its clinical trials were conducted on 19 patients last week. If the test proves successful, the Japanese government will allow its use. In that case, Japan will definitely go one step further in dealing with the coronavirus.

The Japanese government, however, has stockpiled Avigan to deal with influenza. With the current stock of the government, it is possible to treat 6 lakh patients infected with the coronavirus. The Japanese government says it will provide Avigan free of charge if another country requests to use it to treat coronavirus. According to Japanese media, the government has instructed to increase the production of Avigan in the face of Corona expansion. Fuji Film is also considering outsourcing to meet demand.

In addition to Fuji Film, researchers from several other pharmaceutical companies in the country, some government-affiliated research institutes and some of the country’s leading universities are also researching corona drugs. Besides, the effectiveness of some other conventional medicines is also being checked. One such drug is Tecin Pharma Limited’s Cyclosonide, which is marketed under the name Alvesco.

Researchers have found that this steroid inhaler, used to treat asthma, has been used experimentally in a few patients with coronavirus. As a result, research is underway to make it more effective for coronavirus treatment.
Japan’s National World Health and Medical Center said last month it was joining an international initiative to discover drugs for coronavirus.

Attempts are being made to invent not only drugs but also vaccines to cure coronavirus patients. The director-general of the World Health Organization said he was optimistic that such a vaccine would be available in 18 months. However, this process is extremely expensive and time-consuming. According to Ken Ishii, a professor at the University of Tokyo’s Institute of Medical Sciences, “No matter how fast we move toward vaccine discovery, it will take at least a year.”

Japan is taking steps to increase production of coronavirus drugs as well as artificial respirators or ventilators and ECMO devices that work the heart and lungs. Japan is particularly concerned about the rising number of deaths due to machine shortages in the United States and Italy.

However, these devices are quite expensive. Japanese Prime Minister Shinzo Abe told a plenary session of the upper house of parliament on April 3 that by then, 72 of the nearly 3,500 patients diagnosed with coronavirus needed ventilators and that the government had more than 6,000 ventilators to use if needed. On the other hand, there are only 1,400 ECMO machines in hospitals across Japan. The government is now interested in increasing the production of both devices.

Another problem, in this case, is whether there are enough experts in Japan or other countries to operate these devices properly. Norio Omagari, an expert working at Japan’s National World Health Center, said in a recent interview, “The instrument is just an instrument, a team of people engaged in treatment, what brings people together. As a result, it should not be neglected to ensure efficient human resources such as operating machinery.